Tango Therapeutics, Inc. · NASDAQ:TNGX
The Vanguard Group's stake in Tango Therapeutics, Inc. fell below 5% (Schedule 13G/A)
Event Mar 13, 2026 · Filed Mar 27, 2026
The Vanguard Group's stake in Tango Therapeutics, Inc. fell below 5%, 0 shares, as a passive investor on Mar 13, 2026. Filed Mar 27, 2026 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 0% | 0 |
Source
Related
- Tango Therapeutics, Inc.
- The Vanguard Group
- Tango Therapeutics, Inc. shareholders
- Schedule 13G · The Vanguard Group · Jan 30, 2026
- Form 4 · Crystal Adam · Oct 5, 2026
- Form 4 · Newcomb Jessica · Sep 24, 2026
- Form 4 · Crystal Adam · Sep 3, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 14, 2026